Bl. Wilkoff et al., Pacemaker lead extraction with the laser sheath: Results of the pacing lead extraction with the excimer sheath (PLEXES) trial, J AM COL C, 33(6), 1999, pp. 1671-1676
Citations number
17
Categorie Soggetti
Cardiovascular & Respiratory Systems","Cardiovascular & Hematology Research
OBJECTIVES The purpose of this study was to evaluate the safety and effecti
veness of pacemaker lead extraction with the excimer sheath in comparison t
o nonlaser lead extraction.
BACKGROUND Fibrotic attachments that develop between chronically implanted
pacemaker leads and to the venous, valvular and cardiac structures are the
major obstacles to safe and consistent lead extraction. Locking stylets and
telescoping sheaths produce a technically demanding but effective techniqu
e of mechanically disrupting the fibrosis. However, ultraviolet excimer las
er light dissolves instead of tearing the tissue attachments.
METHODS A randomized trial of lead extraction was conducted in 301 patients
with 465 chronically implanted pacemaker leads. The laser group patients h
ad the leads removed with identical tools as the nonlaser group with the ex
ception that the inner telescoping sheath was replaced with the 12-F excime
r laser sheath. Success for both groups was defined as complete lead remova
l with the randomized therapy without complications.
RESULTS Complete lead removal rate was 94% in the laser group and 64% in th
e nonlaser group (p = 0.001). Failed nonlaser extraction was completed with
the laser tools 88% of the time. The mean time to achieve a successful lea
d extraction was significantly reduced for patients randomized to the laser
tools, 10.1 +/- 11.5 min compared with 12.9 +/- 19.2 min for patients rand
omized to nonlaser techniques (p < 0.04). Potentially life-threatening comp
lications occurred in none of the nonlaser and three of the laser patients,
including one death (p = NS).
CONCLUSIONS Laser-assisted pacemaker lead extraction has significant clinic
al advantages over extraction without laser tools and is associated with si
gnificant risks. (C) 1999 by the American College of Cardiology.